Uruguay In-Vitro Diagnostics Market is predicted to reach USD 105.4 Million by 2030

According to the study by Next Move Strategy Consulting, the Uruguay In-Vitro Diagnostics Market size is predicted to reach USD 105.4 million, at a CAGR of 6.2% by 2030.

Request a FREE Sample: https://www.nextmsc.com/uruguay-in-vitro-diagnostic-market/request-sample

Uruguay's substantial investment in healthcare, aimed at ensuring quality healthcare provision, leads to an increased demand for advanced diagnostic techniques such as in vitro diagnostics (IVD).

The escalating prevalence of diabetes in serves as a Uruguay in-vitro diagnostics market growth in the country.

The promising players operating in the Uruguay in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.